Page results
-
UCLH is to host to a new collaboration researching patient safety, after being awarded £3million in funding.
-
Initial results from an early phase study testing the safety and efficacy of a new drug for multiple myeloma have shown a 100 per cent overall response rate in patients with recurrent disease who were given the clinically recommended dose of the investigational drug.
-
This two-part workshop is specially created for teenagers seeking to understand their anxiety more deeply and discover practical, effective strategies to manage it.
-
Bladder cancer is where a growth of abnormal tissue, known as a tumour, develops in the bladder lining. In some cases, the tumour spreads into the surrounding areas.
-
Medtronic are discontinuing the MiniMed™ Mio™ Infusion sets. If you are currently using MiniMed™ Mio™ infusion sets, you will need to change to an alternative infusion set before 31 March 2023. After this date, MiniMed™ Mio™ infusion sets will no longer be available.
-
A national study with initial results shows steroid dexamethasone may substantially reduce mortality in severely ill Covid-19 patients.
-
NHS England has published a proposed interim specification for the new services for children and young people experiencing gender dysphoria.
-
Learn more about how UCLH celebrated Research Open Day this month.
-
This page is for patients who have been asked to take part in a service evaluation looking at Magnetic Resonance Imaging (MRI) at the Proton Beam Therapy department at UCLH. This information explains why we are doing this evaluation and what it would involve for you.
-
Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.
File results
-
FOI/2023/0376 - Director of Estate and Facilities/ Head of Patient Experience contact details
-
FOI/2023/0374 - Stillbirths, neonatal deaths, maternal deaths at Trust from 2018 - 2022
-
FOI/2022/0266 - Drug Patient Level Contract Monitoring (DrPLCM)/ SACT cancer report
-
FOI/2023/0371 - Long Covid paediatric hub
-
FOI/2023/0370 - Trust’s total budget/ spend for inpatient food for 2018 - 2022
-
FOI/2023/0369 - Good Governance Institute spend at the Trust
-
FOI/2023/0367 - IT estate
-
FOI/2023/0337 - Trac systems e-recruitment software used at the Trust
-
FOI/2023/0343 - Clinical guidelines - group B Streptococcus for antenatal, intrapartum and postnatal care
-
FOI/2023/0342 - Self-administration of medication policies